Sign Out
Oral and vaginal administration: Severe liver disease (if the results of liver function tests have failed to return to normal), hepatic cell tumors, rotor syndrome and Dubin-Johnson syndrome.
Hypersensitivity to progesterone or to any of the excipients.
Thrombophlebitis, thromboembolic disorders, cerebral hemorrhage, or history of these conditions.
Carcinoma of the breasts.
Suspected or confirmed breast or genital organ neoplasia.
Undiagnosed vaginal bleeding.
Continue with Google